Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis.
Adult ABO-incompatible liver transplantation has been known to be associated with markedly desperate outcomes. Antibody-mediated rejection (AMR) has been recognized as one of the primary causes of these desperate outcomes, but its clinical features and significance have not been well understood. Recently, some clinicians have succeeded in improving the outcome of adult ABO-incompatible liver transplantation. However, in some transplant patients undergoing these treatments, AMR has still led to graft losses. We recently encountered two patients suffering from AMR after adult ABO-incompatible liver transplantation and remedied their conditions with various therapeutic modalities including direct hepatic infusion therapy and gamma-globulin bolus infusion therapy combined with plasmapheresis. In this article, we describe the clinical features of these patients and the therapeutic strategies we applied. Furthermore, we show the histologic course of the recovery from AMR in the second patient, from whom we were able to extract serial liver biopsies.
Morioka
Daisuke
D
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan. dmorioka@hotmail.com
Sekido
Hitoshi
H
Kubota
Kaori
K
Sugita
Mitsutaka
M
Tanaka
Kuniya
K
Togo
Shinji
S
Yamanaka
Shoji
S
Sasaki
Takeshi
T
Inayama
Yoshiaki
Y
Shimada
Hiroshi
H
D000017:ABO Blood-Group System; D001706:Biopsy; D001787:Blood Group Incompatibility / Q000276:immunology*; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007262:Infusions, Intravenous; D007518:Isoantibodies / Q000276:immunology*; D008099:Liver / Q000378:metabolism / Q000473:pathology; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D010956:Plasmapheresis; D020127:Recovery of Function; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D000017:ABO Blood-Group System; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007518:Isoantibodies; D005719:gamma-Globulins